TD
Telo Genomics Corp.
TDSGF · OTC
$0.03 +0.00% (+$0.00)
1M -50.54%
Market Cap $4.44M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.02
37.5% downside
Trenutna cena
$0.032
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TDSGF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 49.93%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 593.95%
ROA 175.16%
Asset turnover 0.00x
Debt
3 /100
High Current ratio 0.49x
Int. coverage -32.62x
Debt/Equity N/A
Stability
19 /100
Unstable Beta 0.24x
EPS volatility 53.29%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TDSGF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
John Allen Farlinger
Employees
8
Headquarters
Toronto
Prihajajoči dogodki
27 OKT.
Earnings
Upcoming earnings report